XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Equity (Tables)
3 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Common Stock Reserved for Issuance
The Company has shares of common stock reserved for issuance as follows (in thousands):
June 30, 2022March 31, 2022
Common stock warrants641 766 
2010 Plan
Options outstanding22,984 24,312 
2021 Plan
Awards outstanding
1,067 546 
Shares available for future grant31,807 22,466 
2021 ESPP6,395 4,471 
Options outstanding outside the plans2,671 2,671 
Total65,565 55,232 
Stock Option Activity
Stock option activities within the Plans as well as outside of the Plans were as follows (in thousands, except per share information):
Number of SharesWeighted-Average
Exercise Price
Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value
Balance, March 31, 202226,983 $4.15 7.63$1,293,545 
Options exercised(1,079)2.72 
Options forfeited or expired(249)5.80 
Balance, June 30, 202225,655 4.20 7.40785,680 
Vested and exercisable as of June 30, 202210,549 1.96 6.11346,650 
Vested and expected to vest as of June 30, 202223,892 4.09 7.33734,265 
Stock Options Valuation Assumptions
The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:
Three Months Ended June 30,
2021
Fair value of common stock
$18.41 - $21.41
Volatility
46.5% - 47.0%
Risk-free interest rate
0.77% - 1.02%
Expected term (in years)
5.00 - 6.09
Expected dividend
—%
Restricted Stock Unit Activity
The following table summarizes RSU activity during the three months ended June 30, 2022 (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested balance, March 31, 2022534 $68.23 
Granted536 32.99 
Vested(11)53.13 
Forfeited(29)45.42 
Unvested balance, June 30, 20221,030 50.69 
Stock-Based Compensation Expense
Total stock-based compensation expense recognized in the condensed consolidated statement of operations for the three months ended June 30, 2022 and 2021 was as follows (in thousands):
Three Months Ended June 30,
20222021
Cost of revenue$2,122 $268 
Research and development2,552 970 
Sales and marketing3,074 1,028 
General and administrative1,758 2,861 
Total stock-based compensation expense$9,506 $5,127